Monitor The Insider Activity Of agilon health inc. (AGL)

As of Thursday close, agilon health inc.’s (NYSE:AGL) stock was down -$0.93, moving down -3.52 percent to $25.52. The average number of shares traded per day over the past five days has been 2,049,900 shares. 3 times new highs have been achieved over the past 5 days, with a $0.33 gain in that time frame. In the last twenty days, the average volume was 2,300,530, while in the previous 50 days, it was 2,318,840.

Since last month, AGL stock rose 4.29%. Shares of the company fell to $21.97 on 07/05/22, the lowest level in the past month. A 52-week high of $39.10 was reached on 07/21/22 after having rallying from a 52-week low of $14.36. Since the beginning of this year, AGL’s stock price has dropped by -5.48% or -$1.48, and marked a new high 2 times. However, the stock has declined by -34.73% since its 52-week high.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


agilon health inc. (AGL) last reported insider trading activity 15 days ago on Jul 21. Desai Veeral, the Chief Strategy & Dev. Officer of the company, disposed of 79,768 shares for $27.50 on Jul 21. It resulted in a $2,193,620 divestment by the insider. Shaker Benjamin sold 50,000 shares at an average price of $27.72 on Jul 21. The insider now owns 27,132 shares following the transaction. On Jul 20, Chief Markets Officer Shaker Benjamin sold 50,000 shares at $26.38 apiece. The transaction was valued at $1,319,079.

Financial Health

In the three months ended March 30, agilon health inc.’s quick ratio stood at 2.70, while its current ratio was 2.70, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending March 30 was 0.04, and the total debt-to-equity ratio was 0.04. On the profitability front, the trailing twelve-month gross margin is 10.60% percent. In the year ended March 30, operating margins totaled -18.40%. Based on annual data, AGL earned $76.41 million in gross profit and brought in $1.83 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -34.60%. Return on equity (ROE) for the past 12 months was -34.80%.

In agilon health inc.’s quarter-end financial report for March 30, it reported total debt of $42.17 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. AGL’s revenue rose 36.78% to $462.89 million during the quarter, while net income inched up to $653.45 million. While analysts expected agilon health inc. to report $0 quarterly earnings, the actual figure was $0 per share. During the quarter, the company generated $2.63 million in EBITDA. The liabilities of agilon health inc. were 743.73 million at the end of its most recent quarter ended March 30, and its total debt was $55.44 million. The value of shareholders’ equity is $406.73 million.

Technical Picture

This quick technical analysis looks at agilon health inc.’s (AGL) price momentum. With a historical volatility rate of 36.86%, the RSI 9-day stood at 51.64% on 04 August.

With respect to its five-day moving average, the current agilon health inc. price is up by +1.31% percent or $0.33. At present, AGL shares trade -1.66% below its 20-day simple moving average and +17.01% percent above its 100-day simple moving average. However, the stock is currently trading approximately +32.71% above its SMA50 and +8.41% above its SMA200.

Stochastic coefficient K was 46.99% and Stochastic coefficient D was 41.42%, while ATR was 1.28. Given the Stochastic reading of 38.13% for the 14-day period, the RSI (14) reading has been calculated as 54.77%. As of today, the MACD Oscillator reading stands at 0.45, while the 14-day reading stands at 0.22.

Analyst Ratings

BTIG Research launched its rating on agilon health inc. (NYSE: AGL) to a Neutral in a note to investors on June 24, 2022. agilon health inc. (AGL) has been rated Buy by analysts. According to 0 brokerage firms, AGL is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate agilon health inc. stock as buy, with 11 recommending it as overweight.

With a median target price of $32.50, the current consensus forecast for the stock is $23.00 – $41.00. Based on these forecasts, analysts predict agilon health inc. (AGL) will achieve an average price target of $31.70.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles